期刊文献+

Expression of cyclooxygenase-2 mRNA in drug-sensitive cell and drug-resistant strains of ovarian cancer cell lines

Expression of cyclooxygenase-2 mRNA in drug-sensitive cell and drug-resistant strains of ovarian cancer cell lines
下载PDF
导出
摘要 Objective: To investigate the expression of cyclooxygenase-2 (COX-2) mRNA in drug-sensitive cell and drugresistant clones of ovarian cancer cell lines. Methods: RT-PCR and immunocytochemistry were used to investigate the expression of cyclooxygenase-2 in 3 clones drug-sensitive and 5 clones drug-resistant ovarian cancer cell. Results: Strong COX-2 mRNA expressions were detected in 3 clones of drug-sensitive cell and weak expressions were detected in 5 clones of drug-resistant cell. The protein expression of COX-2 in drug-sensitive cell was strongly positive reaction in immunocytochemistry stain and there was a weak positive reaction in 5 clones of drug-resistant cell. Conclusion: The expression of COX-2 mRNA in drug-sensitive cell strains is much higher than that in drugresistant strains of ovarian cancer cell lines, providing a basis of the chemoprevention for ovarian cancer. Objective: To investigate the expression of cyclooxygenase-2 (COX-2) mRNA in drug-sensitive cell and drugresistant clones of ovarian cancer cell lines. Methods: RT-PCR and immunocytochemistry were used to investigate the expression of cyclooxygenase-2 in 3 clones drug-sensitive and 5 clones drug-resistant ovarian cancer cell. Results: Strong COX-2 mRNA expressions were detected in 3 clones of drug-sensitive cell and weak expressions were detected in 5 clones of drug-resistant cell. The protein expression of COX-2 in drug-sensitive cell was strongly positive reaction in immunocytochemistry stain and there was a weak positive reaction in 5 clones of drug-resistant cell. Conclusion: The expression of COX-2 mRNA in drug-sensitive cell strains is much higher than that in drugresistant strains of ovarian cancer cell lines, providing a basis of the chemoprevention for ovarian cancer.
出处 《Journal of Nanjing Medical University》 2006年第1期52-54,共3页 南京医科大学学报(英文版)
基金 National Natural Science Foundation of China (No.30070786)
关键词 ovarian cancer cell lines drug-sensitive cell strains drug-resistant strains cyclooxygelmse-2 ovarian cancer cell lines drug-sensitive cell strains drug-resistant strains cyclooxygelmse-2
  • 相关文献

参考文献8

  • 1Charles N,Landen JM,Subbi PM,et al.Expression of cyclooxyge- nacase-2 in cervical , endometrial , and ovarian malignancies[].American Journal of Obstetrics and Gynecology.2003
  • 2Ferrandina G,Lauriola L,Zannoni GF,et al.Increased cyclooxyge- nacase-2 (cox-2) expression is associated with chemotherapy resis- tance and outcome in ovarian cancer patients[].Annals of Oncology.2002
  • 3Howe LR,Dannenberg AJ.Arole for cyclooxygenacase-2 inhibitors inthe preventionandtreatment of cancer[].Seminars in Oncology.2002
  • 4Rouba AF,Mingxin Che,IbrahimK,et al.The effects of cyclooxy- genacase-2 expression ontumors vascularutyinadvancedstage ovarian serous carcinoma[].Cancer.2003
  • 5Ferrandina G,Lauriola MG,Distefano GF,et al.Increased cy- clooxygenacase-2 (cox-2) expressionis associated with chemotherapy resistance and poor survival in cervical cancer patients[].J of Clinical Oncol.2002
  • 6Ferrandina G,Ranelletti FO,Lauriola L,et al.Cyclooxygenacase-2 (cox-2) ,epidermal growth factor receptor (EGFR) ,and her-2/neu expressionin ovarian cancer[].Gynecologic Oncology.2002
  • 7Dannenberg AJ,Altorki NK,Boyle JO,et al.Cyclo-oxygenacase2 :a pharmacological target forthe preventionof cancer[].The Lancet Oncology.2001
  • 8Mills GB,Schmandt R,Gershenson D,et al.Should therapy of o- varian cancer patients be individualized based on underlying genetic defects[].Clinical Cancer Research.1999

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部